Loading…
Protective Effect of Melanocortin Peptides in Rat Myocardial Ischemia
The influence of the melanocortin peptide ACTH-(1-24) (adrenocorticotropin) on the consequences of short-term coronary ischemia (5 min) followed by reperfusion, and the effect of the long-acting melanocortin [Nle4,d-Phe7]α-melanocyte-stimulating hormone (NDP-MSH) on the damage induced by a permanent...
Saved in:
Published in: | The Journal of pharmacology and experimental therapeutics 2001-06, Vol.297 (3), p.1082-1087 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c341t-5fedf858a707be06b0554b17ad4ad424e41e15ef31612a4481ce9424674f17e73 |
container_end_page | 1087 |
container_issue | 3 |
container_start_page | 1082 |
container_title | The Journal of pharmacology and experimental therapeutics |
container_volume | 297 |
creator | Bazzani, Carla Guarini, Salvatore Botticelli, Annibale R. Zaffe, Davide Tomasi, Aldo Bini, Anna Cainazzo, Maria Michela Ferrazza, Giuseppe Mioni, Chiara Bertolini, Alfio |
description | The influence of the melanocortin peptide ACTH-(1-24) (adrenocorticotropin) on the consequences of short-term coronary ischemia (5 min) followed by reperfusion, and the effect of the long-acting melanocortin [Nle4,d-Phe7]α-melanocyte-stimulating hormone (NDP-MSH) on the damage induced by a permanent coronary occlusion, were investigated in anesthetized rats. Ischemia was produced by ligature of the left anterior descending coronary artery. Reperfusion-induced arrhythmias [ventricular tachycardia (VT), ventricular fibrillation (VF)] and survival rate within the 5 min following reperfusion, blood levels of free radicals detected 2 min after reperfusion by electron spin resonance spectrometry, and amount of healthy myocardial tissue, measured 72 h after permanent coronary occlusion on immunohistologically stained serial sections, were evaluated. Postischemic reperfusion induced VT in all saline-treated rats, and VF and death in a high percentage of animals (87%). In rats treated i.v. (2.5 min after coronary occlusion) with ACTH-(1-24) (0.16–0.48 mg/kg) there was a significantly dose-dependent reduction in the incidence of arrhythmias and lethality. Ischemia/reperfusion caused a large increase in free radical blood levels; treatment with ACTH-(1-24) (0.48 mg/kg i.v.) almost completely prevented this increase. In rats subjected to permanent coronary occlusion, the amount of healthy myocardial tissue was much reduced in saline-treated rats, while in rats treated s.c. with NDP-MSH (0.27 mg/kg every 12 h) it was significantly higher. The present data demonstrate, for the first time, an unforeseen property of melanocortin peptides, i.e., their ability to significantly reduce both heart ischemia/reperfusion injury and size of the ischemic area induced by permanent coronary occlusion. |
doi_str_mv | 10.1016/S0022-3565(24)29636-1 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70855931</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022356524296361</els_id><sourcerecordid>70855931</sourcerecordid><originalsourceid>FETCH-LOGICAL-c341t-5fedf858a707be06b0554b17ad4ad424e41e15ef31612a4481ce9424674f17e73</originalsourceid><addsrcrecordid>eNqFkFlLAzEQx4MoWo-PoOyTx8NqJsfu9klE6gGKxeM5pNmJjew2Ndkq_famB_ooBDIMv__M8CPkEOg5UCguXihlLOeykKdMnLF-wYscNkgPJIOcAuWbpPeL7JDdGD8oBSEKvk12AFK3z1mPDIbBd2g694XZwNpUZd5mj9joiTc-dG6SDXHauRpjlupn3WWPc290qJ1usvtoxtg6vU-2rG4iHqz_PfJ2M3i9vssfnm7vr68ecsMFdLm0WNtKVrqk5QhpMaJSihGUuhbpMYECECRaDgUwLUQFBvupX5TCQokl3yPHq7nT4D9nGDvVumiwSdein0VV0krKPocEyhVogo8xoFXT4Fod5gqoWvhTS39qIUcxoZb-1CJ3tF4wG7VY_6XWwhJwsgLG7n387QKq6ViHVhvf-Pd5mlMqnhZUC_JyRWIS8uUwqGgcTgzWKWU6VXv3zzE_DZWL2Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70855931</pqid></control><display><type>article</type><title>Protective Effect of Melanocortin Peptides in Rat Myocardial Ischemia</title><source>Alma/SFX Local Collection</source><creator>Bazzani, Carla ; Guarini, Salvatore ; Botticelli, Annibale R. ; Zaffe, Davide ; Tomasi, Aldo ; Bini, Anna ; Cainazzo, Maria Michela ; Ferrazza, Giuseppe ; Mioni, Chiara ; Bertolini, Alfio</creator><creatorcontrib>Bazzani, Carla ; Guarini, Salvatore ; Botticelli, Annibale R. ; Zaffe, Davide ; Tomasi, Aldo ; Bini, Anna ; Cainazzo, Maria Michela ; Ferrazza, Giuseppe ; Mioni, Chiara ; Bertolini, Alfio</creatorcontrib><description>The influence of the melanocortin peptide ACTH-(1-24) (adrenocorticotropin) on the consequences of short-term coronary ischemia (5 min) followed by reperfusion, and the effect of the long-acting melanocortin [Nle4,d-Phe7]α-melanocyte-stimulating hormone (NDP-MSH) on the damage induced by a permanent coronary occlusion, were investigated in anesthetized rats. Ischemia was produced by ligature of the left anterior descending coronary artery. Reperfusion-induced arrhythmias [ventricular tachycardia (VT), ventricular fibrillation (VF)] and survival rate within the 5 min following reperfusion, blood levels of free radicals detected 2 min after reperfusion by electron spin resonance spectrometry, and amount of healthy myocardial tissue, measured 72 h after permanent coronary occlusion on immunohistologically stained serial sections, were evaluated. Postischemic reperfusion induced VT in all saline-treated rats, and VF and death in a high percentage of animals (87%). In rats treated i.v. (2.5 min after coronary occlusion) with ACTH-(1-24) (0.16–0.48 mg/kg) there was a significantly dose-dependent reduction in the incidence of arrhythmias and lethality. Ischemia/reperfusion caused a large increase in free radical blood levels; treatment with ACTH-(1-24) (0.48 mg/kg i.v.) almost completely prevented this increase. In rats subjected to permanent coronary occlusion, the amount of healthy myocardial tissue was much reduced in saline-treated rats, while in rats treated s.c. with NDP-MSH (0.27 mg/kg every 12 h) it was significantly higher. The present data demonstrate, for the first time, an unforeseen property of melanocortin peptides, i.e., their ability to significantly reduce both heart ischemia/reperfusion injury and size of the ischemic area induced by permanent coronary occlusion.</description><identifier>ISSN: 0022-3565</identifier><identifier>EISSN: 1521-0103</identifier><identifier>DOI: 10.1016/S0022-3565(24)29636-1</identifier><identifier>PMID: 11356932</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject><![CDATA[alpha-MSH - administration & dosage ; alpha-MSH - analogs & derivatives ; Animals ; Arrhythmias, Cardiac - prevention & control ; Coronary Disease - drug therapy ; Coronary Disease - metabolism ; Cosyntropin - administration & dosage ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Electrocardiography - drug effects ; Electron Spin Resonance Spectroscopy ; Female ; Free Radicals - antagonists & inhibitors ; Free Radicals - blood ; Injections, Intravenous ; Injections, Subcutaneous ; Male ; Myocardial Ischemia - drug therapy ; Myocardial Ischemia - metabolism ; Myocardial Ischemia - pathology ; Myocardial Reperfusion ; Neuropeptides - administration & dosage ; Rats ; Rats, Wistar ; Reperfusion Injury - metabolism ; Reperfusion Injury - prevention & control ; Survival Rate]]></subject><ispartof>The Journal of pharmacology and experimental therapeutics, 2001-06, Vol.297 (3), p.1082-1087</ispartof><rights>2001 American Society for Pharmacology and Experimental Therapeutics</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c341t-5fedf858a707be06b0554b17ad4ad424e41e15ef31612a4481ce9424674f17e73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11356932$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bazzani, Carla</creatorcontrib><creatorcontrib>Guarini, Salvatore</creatorcontrib><creatorcontrib>Botticelli, Annibale R.</creatorcontrib><creatorcontrib>Zaffe, Davide</creatorcontrib><creatorcontrib>Tomasi, Aldo</creatorcontrib><creatorcontrib>Bini, Anna</creatorcontrib><creatorcontrib>Cainazzo, Maria Michela</creatorcontrib><creatorcontrib>Ferrazza, Giuseppe</creatorcontrib><creatorcontrib>Mioni, Chiara</creatorcontrib><creatorcontrib>Bertolini, Alfio</creatorcontrib><title>Protective Effect of Melanocortin Peptides in Rat Myocardial Ischemia</title><title>The Journal of pharmacology and experimental therapeutics</title><addtitle>J Pharmacol Exp Ther</addtitle><description>The influence of the melanocortin peptide ACTH-(1-24) (adrenocorticotropin) on the consequences of short-term coronary ischemia (5 min) followed by reperfusion, and the effect of the long-acting melanocortin [Nle4,d-Phe7]α-melanocyte-stimulating hormone (NDP-MSH) on the damage induced by a permanent coronary occlusion, were investigated in anesthetized rats. Ischemia was produced by ligature of the left anterior descending coronary artery. Reperfusion-induced arrhythmias [ventricular tachycardia (VT), ventricular fibrillation (VF)] and survival rate within the 5 min following reperfusion, blood levels of free radicals detected 2 min after reperfusion by electron spin resonance spectrometry, and amount of healthy myocardial tissue, measured 72 h after permanent coronary occlusion on immunohistologically stained serial sections, were evaluated. Postischemic reperfusion induced VT in all saline-treated rats, and VF and death in a high percentage of animals (87%). In rats treated i.v. (2.5 min after coronary occlusion) with ACTH-(1-24) (0.16–0.48 mg/kg) there was a significantly dose-dependent reduction in the incidence of arrhythmias and lethality. Ischemia/reperfusion caused a large increase in free radical blood levels; treatment with ACTH-(1-24) (0.48 mg/kg i.v.) almost completely prevented this increase. In rats subjected to permanent coronary occlusion, the amount of healthy myocardial tissue was much reduced in saline-treated rats, while in rats treated s.c. with NDP-MSH (0.27 mg/kg every 12 h) it was significantly higher. The present data demonstrate, for the first time, an unforeseen property of melanocortin peptides, i.e., their ability to significantly reduce both heart ischemia/reperfusion injury and size of the ischemic area induced by permanent coronary occlusion.</description><subject>alpha-MSH - administration & dosage</subject><subject>alpha-MSH - analogs & derivatives</subject><subject>Animals</subject><subject>Arrhythmias, Cardiac - prevention & control</subject><subject>Coronary Disease - drug therapy</subject><subject>Coronary Disease - metabolism</subject><subject>Cosyntropin - administration & dosage</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug Administration Schedule</subject><subject>Electrocardiography - drug effects</subject><subject>Electron Spin Resonance Spectroscopy</subject><subject>Female</subject><subject>Free Radicals - antagonists & inhibitors</subject><subject>Free Radicals - blood</subject><subject>Injections, Intravenous</subject><subject>Injections, Subcutaneous</subject><subject>Male</subject><subject>Myocardial Ischemia - drug therapy</subject><subject>Myocardial Ischemia - metabolism</subject><subject>Myocardial Ischemia - pathology</subject><subject>Myocardial Reperfusion</subject><subject>Neuropeptides - administration & dosage</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Reperfusion Injury - metabolism</subject><subject>Reperfusion Injury - prevention & control</subject><subject>Survival Rate</subject><issn>0022-3565</issn><issn>1521-0103</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNqFkFlLAzEQx4MoWo-PoOyTx8NqJsfu9klE6gGKxeM5pNmJjew2Ndkq_famB_ooBDIMv__M8CPkEOg5UCguXihlLOeykKdMnLF-wYscNkgPJIOcAuWbpPeL7JDdGD8oBSEKvk12AFK3z1mPDIbBd2g694XZwNpUZd5mj9joiTc-dG6SDXHauRpjlupn3WWPc290qJ1usvtoxtg6vU-2rG4iHqz_PfJ2M3i9vssfnm7vr68ecsMFdLm0WNtKVrqk5QhpMaJSihGUuhbpMYECECRaDgUwLUQFBvupX5TCQokl3yPHq7nT4D9nGDvVumiwSdein0VV0krKPocEyhVogo8xoFXT4Fod5gqoWvhTS39qIUcxoZb-1CJ3tF4wG7VY_6XWwhJwsgLG7n387QKq6ViHVhvf-Pd5mlMqnhZUC_JyRWIS8uUwqGgcTgzWKWU6VXv3zzE_DZWL2Q</recordid><startdate>200106</startdate><enddate>200106</enddate><creator>Bazzani, Carla</creator><creator>Guarini, Salvatore</creator><creator>Botticelli, Annibale R.</creator><creator>Zaffe, Davide</creator><creator>Tomasi, Aldo</creator><creator>Bini, Anna</creator><creator>Cainazzo, Maria Michela</creator><creator>Ferrazza, Giuseppe</creator><creator>Mioni, Chiara</creator><creator>Bertolini, Alfio</creator><general>Elsevier Inc</general><general>American Society for Pharmacology and Experimental Therapeutics</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200106</creationdate><title>Protective Effect of Melanocortin Peptides in Rat Myocardial Ischemia</title><author>Bazzani, Carla ; Guarini, Salvatore ; Botticelli, Annibale R. ; Zaffe, Davide ; Tomasi, Aldo ; Bini, Anna ; Cainazzo, Maria Michela ; Ferrazza, Giuseppe ; Mioni, Chiara ; Bertolini, Alfio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c341t-5fedf858a707be06b0554b17ad4ad424e41e15ef31612a4481ce9424674f17e73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>alpha-MSH - administration & dosage</topic><topic>alpha-MSH - analogs & derivatives</topic><topic>Animals</topic><topic>Arrhythmias, Cardiac - prevention & control</topic><topic>Coronary Disease - drug therapy</topic><topic>Coronary Disease - metabolism</topic><topic>Cosyntropin - administration & dosage</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug Administration Schedule</topic><topic>Electrocardiography - drug effects</topic><topic>Electron Spin Resonance Spectroscopy</topic><topic>Female</topic><topic>Free Radicals - antagonists & inhibitors</topic><topic>Free Radicals - blood</topic><topic>Injections, Intravenous</topic><topic>Injections, Subcutaneous</topic><topic>Male</topic><topic>Myocardial Ischemia - drug therapy</topic><topic>Myocardial Ischemia - metabolism</topic><topic>Myocardial Ischemia - pathology</topic><topic>Myocardial Reperfusion</topic><topic>Neuropeptides - administration & dosage</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Reperfusion Injury - metabolism</topic><topic>Reperfusion Injury - prevention & control</topic><topic>Survival Rate</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bazzani, Carla</creatorcontrib><creatorcontrib>Guarini, Salvatore</creatorcontrib><creatorcontrib>Botticelli, Annibale R.</creatorcontrib><creatorcontrib>Zaffe, Davide</creatorcontrib><creatorcontrib>Tomasi, Aldo</creatorcontrib><creatorcontrib>Bini, Anna</creatorcontrib><creatorcontrib>Cainazzo, Maria Michela</creatorcontrib><creatorcontrib>Ferrazza, Giuseppe</creatorcontrib><creatorcontrib>Mioni, Chiara</creatorcontrib><creatorcontrib>Bertolini, Alfio</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of pharmacology and experimental therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bazzani, Carla</au><au>Guarini, Salvatore</au><au>Botticelli, Annibale R.</au><au>Zaffe, Davide</au><au>Tomasi, Aldo</au><au>Bini, Anna</au><au>Cainazzo, Maria Michela</au><au>Ferrazza, Giuseppe</au><au>Mioni, Chiara</au><au>Bertolini, Alfio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Protective Effect of Melanocortin Peptides in Rat Myocardial Ischemia</atitle><jtitle>The Journal of pharmacology and experimental therapeutics</jtitle><addtitle>J Pharmacol Exp Ther</addtitle><date>2001-06</date><risdate>2001</risdate><volume>297</volume><issue>3</issue><spage>1082</spage><epage>1087</epage><pages>1082-1087</pages><issn>0022-3565</issn><eissn>1521-0103</eissn><abstract>The influence of the melanocortin peptide ACTH-(1-24) (adrenocorticotropin) on the consequences of short-term coronary ischemia (5 min) followed by reperfusion, and the effect of the long-acting melanocortin [Nle4,d-Phe7]α-melanocyte-stimulating hormone (NDP-MSH) on the damage induced by a permanent coronary occlusion, were investigated in anesthetized rats. Ischemia was produced by ligature of the left anterior descending coronary artery. Reperfusion-induced arrhythmias [ventricular tachycardia (VT), ventricular fibrillation (VF)] and survival rate within the 5 min following reperfusion, blood levels of free radicals detected 2 min after reperfusion by electron spin resonance spectrometry, and amount of healthy myocardial tissue, measured 72 h after permanent coronary occlusion on immunohistologically stained serial sections, were evaluated. Postischemic reperfusion induced VT in all saline-treated rats, and VF and death in a high percentage of animals (87%). In rats treated i.v. (2.5 min after coronary occlusion) with ACTH-(1-24) (0.16–0.48 mg/kg) there was a significantly dose-dependent reduction in the incidence of arrhythmias and lethality. Ischemia/reperfusion caused a large increase in free radical blood levels; treatment with ACTH-(1-24) (0.48 mg/kg i.v.) almost completely prevented this increase. In rats subjected to permanent coronary occlusion, the amount of healthy myocardial tissue was much reduced in saline-treated rats, while in rats treated s.c. with NDP-MSH (0.27 mg/kg every 12 h) it was significantly higher. The present data demonstrate, for the first time, an unforeseen property of melanocortin peptides, i.e., their ability to significantly reduce both heart ischemia/reperfusion injury and size of the ischemic area induced by permanent coronary occlusion.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>11356932</pmid><doi>10.1016/S0022-3565(24)29636-1</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-3565 |
ispartof | The Journal of pharmacology and experimental therapeutics, 2001-06, Vol.297 (3), p.1082-1087 |
issn | 0022-3565 1521-0103 |
language | eng |
recordid | cdi_proquest_miscellaneous_70855931 |
source | Alma/SFX Local Collection |
subjects | alpha-MSH - administration & dosage alpha-MSH - analogs & derivatives Animals Arrhythmias, Cardiac - prevention & control Coronary Disease - drug therapy Coronary Disease - metabolism Cosyntropin - administration & dosage Dose-Response Relationship, Drug Drug Administration Schedule Electrocardiography - drug effects Electron Spin Resonance Spectroscopy Female Free Radicals - antagonists & inhibitors Free Radicals - blood Injections, Intravenous Injections, Subcutaneous Male Myocardial Ischemia - drug therapy Myocardial Ischemia - metabolism Myocardial Ischemia - pathology Myocardial Reperfusion Neuropeptides - administration & dosage Rats Rats, Wistar Reperfusion Injury - metabolism Reperfusion Injury - prevention & control Survival Rate |
title | Protective Effect of Melanocortin Peptides in Rat Myocardial Ischemia |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T14%3A24%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Protective%20Effect%20of%20Melanocortin%20Peptides%20in%20Rat%20Myocardial%20Ischemia&rft.jtitle=The%20Journal%20of%20pharmacology%20and%20experimental%20therapeutics&rft.au=Bazzani,%20Carla&rft.date=2001-06&rft.volume=297&rft.issue=3&rft.spage=1082&rft.epage=1087&rft.pages=1082-1087&rft.issn=0022-3565&rft.eissn=1521-0103&rft_id=info:doi/10.1016/S0022-3565(24)29636-1&rft_dat=%3Cproquest_cross%3E70855931%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c341t-5fedf858a707be06b0554b17ad4ad424e41e15ef31612a4481ce9424674f17e73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=70855931&rft_id=info:pmid/11356932&rfr_iscdi=true |